EURODIAB IDDM, which was a study assessing the presence of DM complications in which more than three thousand patients from sixteen countries were treated with insulin, initially found neuropathy in 28% of patients, and an increase to 51.5% was recorded after a seven-year follow-up [124]. Here, INS is linked to diabetes mellitus.